Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.9
4.9
Journals
Pharmaceutics
Special Issues
Drug Design and Targeting
share announcement

Drug Design and Targeting

A special issue of Pharmaceutics (ISSN 1999-4923).

Deadline for manuscript submissions: closed (31 July 2011) | Viewed by 10374

Special Issue Editor

Prof. Dr. Nicholas Bodor

E-Mail
Guest Editor
Center for Drug Discovery, University of Florida, P.O. Box 100497, Gainesville, FL 32610, USA
Interests: retrometabolic design; soft drugs; chemical-enzymatic targeting; computer assisted drug design; metabolism

Keywords

  • prodrugs
  • soft drugs
  • drug metabolism
  • drug transport
  • drug distribution
  • retrometabolic design
  • receptor binding
  • isosteric
  • isoelectronic
  • analog design
  • computer assisted drug design
  • inclusion complexes
  • controlled release

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Review

931 KiB  
Review
Ionic Channels as Targets for Drug Design: A Review on Computational Methods
by Gregorio Fernández-Ballester, Asia Fernández-Carvajal, José Manuel González-Ros and Antonio Ferrer-Montiel
Pharmaceutics 2011, 3(4), 932-953; https://doi.org/10.3390/pharmaceutics3040932 - 9 Dec 2011
Cited by 25 | Viewed by 9743
Abstract
Ion channels are involved in a broad range of physiological and pathological processes. The implications of ion channels in a variety of diseases, including diabetes, epilepsy, hypertension, cancer and even chronic pain, have signaled them as pivotal drug targets. Thus far, drugs targeting [...] Read more.
Ion channels are involved in a broad range of physiological and pathological processes. The implications of ion channels in a variety of diseases, including diabetes, epilepsy, hypertension, cancer and even chronic pain, have signaled them as pivotal drug targets. Thus far, drugs targeting ion channels were developed without detailed knowledge of the molecular interactions between the lead compounds and the target channels. In recent years, however, the emergence of high-resolution structures for a plethora of ion channels paves the way for computer-assisted drug design. Currently, available functional and structural data provide an attractive platform to generate models that combine substrate-based and protein-based approaches. In silico approaches include homology modeling, quantitative structure-activity relationships, virtual ligand screening, similarity and pharmacophore searching, data mining, and data analysis tools. These strategies have been frequently used in the discovery and optimization of novel molecules with enhanced affinity and specificity for the selected therapeutic targets. In this review we summarize recent applications of in silico methods that are being used for the development of ion channel drugs. Full article
(This article belongs to the Special Issue Drug Design and Targeting)
►▼ Show Figures

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop